Patents by Inventor Troy Albert Reaves

Troy Albert Reaves has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Photodynamic therapy of occult age-related macular degeneration
    Patent number: 8034803
    Abstract: The invention relates to the selection and treatment of subjects afflicted with occult choroidal neovascular lesions, including subjects with age-related macular degeneration, by use of photo dynamic therapy (PDT).
    Type: Grant
    Filed: February 6, 2002
    Date of Patent: October 11, 2011
    Assignees: QLT Inc., Novartis, A.G.
    Inventors: H. Andrew Strong, Mohammad Azab, Yong Hao, John Miller Koester, Troy Albert Reaves, Jr.
  • Method to prevent vision loss
    Patent number: 7060695
    Abstract: An improved method to treat conditions of the eye characterized by ocular neovascularization is provided in which patients are given and initial photodynamic therapy (PDT) treatment to destroy the neovasculature, and then are re-evaluated at least twice during the following 6 months, and retreated as necessary. Preferably, three retreatments are provided.
    Type: Grant
    Filed: February 6, 2002
    Date of Patent: June 13, 2006
    Assignees: QLT, Inc., Novartis AG
    Inventors: H. Andrew Strong, Mohammad Azab, Troy Albert Reaves, Jr.
  • Photodynamic therapy of occult age-related macular degeneration
    Publication number: 20030087889
    Abstract: The invention relates to the selection and treatment of subjects afflicted with occult choroidal neovascular lesions, including subjects with age-related macular degeneration, by use of photo dynamic therapy (PDT).
    Type: Application
    Filed: February 6, 2002
    Publication date: May 8, 2003
    Inventors: H. Andrew Strong, Mohammad Azab, Yong Hao, John Miller Koester, Troy Albert Reaves
  • Method to prevent vision loss
    Publication number: 20020183302
    Abstract: An improved method to treat conditions of the eye characterized by ocular neovascularization is provided in which patients are given and initial photodynamic therapy (PDT) treatment to destroy the neovasculature, and then are re-evaluated at least twice during the following 6 months, and retreated as necessary. Preferably, three retreatments are provided.
    Type: Application
    Filed: February 6, 2002
    Publication date: December 5, 2002
    Inventors: H. Andrew Strong, Mohammad Azab Ali, Troy Albert Reaves